Curriculum-Based Online and Live Activities


Course Director
Todd Dylan Levine, MD
Kansas University
Phoenix Neurological Associates
Phoenix, Arizona

Curriculum Description

A chronic, acquired, immune-mediated disorder affecting the peripheral nervous system, chronic inflammatory demyelinating polyneuropathy (CIDP) has been classically characterized by progressive limb weakness, sensory loss, and areflexia with a relapsing or progressive course. Responsiveness to immune therapies—such as corticosteroids, plasma exchange, and intravenous immune globulin (IVIg)—is considered a hallmark of the disease. CIDP remains a diagnostic challenge because of its typically insidious onset, complex differential diagnosis, atypical presentations, and multifaceted testing requirements. Although the exact cause of CIDP remains unknown, abnormalities in both cellular and humoral immunity have been demonstrated, and ongoing research is providing new insights on the mechanism and subtypes of disease. In addition, novel treatment strategies, such as a subcutaneous immune globulin, may soon provide new options for these patients.

Through this curriculum, we hope to shed light on the complexities associated with diagnosing and differentiating CIDP from other immune-mediated neuromuscular disorders, and offer insights on the latest advances for disease management. Real-world case studies will highlight the practicalities of patient care and focus on the importance of shared decision-making. To learn more, join Dr. Todd Dylan Levine for this engaging educational talk, or request to host this lecture at your annual AAN state neurosociety meeting.

Target Audience

The activity has been designed to meet the educational needs of neurologists, neuromuscular and neurophysiology specialists, and other clinicians involved in the care of patients with CIDP.